Live Breaking News & Updates on ஆராய்ச்சி சபை ஆஸ்திரேலியா

Stay updated with breaking news from ஆராய்ச்சி சபை ஆஸ்திரேலியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients


NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients
Therapeutic anticoagulation trials is looking at which blood thinners are best to use to treat COVID-caused venous thrombosis embolism (VTE)
Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al. 
December 23, 2020 Three clinical trial platforms working together to test the effects of full doses of anticoagulants in COVID-19 patients have paused enrollment for one group of patients. Among critically ill COVID-19 (SARS-CoV-2) patients requiring intensive care unit (ICU) support, therapeutic anticoagulation drugs did not reduce the need for organ support. Enrollment continues for moderately ill hospitalized COVID-19 patients in the tri ....

United States , New York , New York University , Margarita Rezvin , National Health , National Institutes Of Health , Adaptive Platform Trial For Community , Canadian Institutes Of Health Research , National Institute For Health Research , University Of Pittsburgh , Research Council Australia , York University , National Heart , Blood Institute , Widespread Blood Clots , Trials Looking , Anticoaguation Strategies , Multi Factorial Adaptive Platform Trial , Community Acquired Pneumonia , Therapeutic Anticoagulation , Antithrombotics Inpatient , Antithrombotic Therapy , Ameliorate Complications , Canadian Institutes , Health Research , National Institute ,